Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 23, 2022 2:07 PM 3 min read

Why Tilray, Canopy Growth Look Set For New Highs Despite Failing To Hold After-Hours Surge

by Melanie Schaffer Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Canopy Growth Corporation (NASDAQ:CGC) and Tilray, Inc (NASDAQ:TLRY) gapped up slightly higher on Wednesday after running up to 7.43% and 12.87%, respectively, in the after-hours trading session on Tuesday.

The beaten down cannabis sector has seen renewed interest recently, with several high-profile mergers and acquisitions making headlines as the larger producers attempt to gain control over the market. The most recent acquisition, which was announced on Tuesday, will see Cresco Labs, Inc (OTC:CRLBF) acquire Columbia Care (OTC:CCHWF) for a whopping $2.1 billion.

The deal will make Cresco Labs the leader in the North American cannabis industry, with yearly revenue of over $1.3 billion.

Canopy Growth and Tilray, which are also leaders in the space, have made several acquisitions as well over the past few years. Perhaps most notably, Canopy Growth acquired Supreme Cannabis Co in April 2021 for $345 million and in May of last year, Tilray merged with Aphria Inc. to create the “new” Tilray with a combined market cap of $3.3 billion at that time.

Even as the vast number of companies who jumped into the space in the run-up to legalization in Canada continues to consolidate, the seeming unwillingness of the U.S. government to make cannabis legal at the federal level is likely to continue weighing the stocks down. For technical traders, however, both Canopy Growth and Tilray are flashing signs the bottom may be in and a larger rebound to the upside may be on the horizon.

It should be noted, however, that events such the general markets turning bearish, negative reactions to earnings prints and negative news headlines about a stock can quickly invalidate bullish patterns and break-outs. As the saying goes, “the trend is your friend until it isn’t” and any trader in a bullish position should have a clear stop set in place and manage their risk versus reward.

See Also: Can Marijuana Help Reduce PMS Symptoms? Canopy Growth's CBD Efficacy Study Reveals

The Canopy Growth Chart: On March 14 and March 15, Canopy Growth printed a bullish double bottom pattern near the 52-week low of $5.62 and has since reacted to the formation, soaring up 37.48% to reach a high-of-day on Wednesday of $7.74.

  • On Tuesday, Canopy Growth fell lower to open the trading day just above the eight-day exponential moving average, which set a higher low to confirm the stock is now trading in an uptrend. For the trend to continue, Canopy Growth will need to remain above the $6.80 level on the next pullback.
  • Canopy Growth attempted to regain support at the 50-day simple moving average (SMA) on Wednesday morning, but failed and rejected the level. Bullish traders will want to see the stock regain the 200-day as support over the coming days, which would indicate longer-term sentiment has turned bullish.
  • Canopy Growth has resistance above at $7.36 and $9 and support below at $6.12 and $5.63.

Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial.

The Tilray Chart: Like Canopy Growth, Tilray printed a double bottom pattern at the $4.81 level on March 14 and March 15 and surged up 31.8% higher to reach a high of $6.30 on Wednesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
CannabisPenny StocksTechnicalsSmall CapMarketsMoversTrading Ideas
CGC Logo
CGCCanopy Growth Corp
$1.16-0.85%
Overview
TLRY Logo
TLRYTilray Brands Inc
$7.74-0.51%
CRLBF Logo
CRLBFCresco Labs Inc
$1.114.72%
  • Tilray confirmed it is trading in an uptrend on March 21, when the stock printed a higher low at the $5.27 level. For the trend to continue, Tilray will need to print another higher low above that level on the next retracement.
  • On Wednesday, Tilray regained the eight-day and 21-day EMAs as support, which may give bulls more confidence going forward. The eight-day EMA is trending below the 21-day, however, and bullish traders will want to see the stock remain above the 21-day in order to cause an eventual cross of the two EMAs.
  • Tilray has resistance above at $5.90 and $6.46 and support below at $5.15 and $4.81.
CGC Logo
CGCCanopy Growth Corp
$1.16-0.85%
Overview
TLRY Logo
TLRYTilray Brands Inc
$7.74-0.51%
CRLBF Logo
CRLBFCresco Labs Inc
$1.114.72%
Comments
Loading...